International regulators align positions on phase 3 COVID-19 vaccine trials

During the second workshop on Covid-19 vaccine development, participants agreed regulatory positions on: 1) data needed from lab, animal and human studies to allow initiation of Phase III clinical trials, and 2) considerations for Phase III study design.


European Medicines Agency